Incretin-based therapies and their future in Type 2 diabetes mellitus

Author： Sonnett Travis E   Robinson Jennifer D   Bowen Kurt A  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.8, Iss.2, 2011-03, pp. : 143-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incorporating Incretin-Based Therapies into Clinical Practice for Patients with Type 2 Diabetes

By Tibaldi Joseph  

Advances in Therapy, Vol. 31, Iss. 3, 2014-03 ,pp. : 289-317

Springer Publishing Company

Access to resources Recommend Favorite

Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies

By Meece Jerry  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 933-944

Informa Healthcare

Access to resources Recommend Favorite

Incretin‐based medications for type 2 diabetes: an overview of reviews

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 7, 2015-07 ,pp. : 649-658

John Wiley & Sons Inc

Access to resources Recommend Favorite

Implications of incretin‐based therapies on cardiovascular disease

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 5, 2015-05 ,pp. : 531-549

John Wiley & Sons Inc

Access to resources Recommend Favorite

Type 2 diabetes mellitus and bone

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 283, Iss. 2, 2018-02 ,pp. : 140-153

John Wiley & Sons Inc

Access to resources Recommend Favorite